The rotenone model of parkinsonism--the five years inspection.
نویسندگان
چکیده
Treatment of rats with rotenone has been proposed in the year 2000 to provide an animal model of idiopathic Parkinson's disease. We review here the experience that has been gained meanwhile with this model. The published data suggest that the model does not ideally reproduce the pathophysiology of Parkinson's disease, that Rotenone treatment does not cause a purely neurodegenerative concondition, that the Rotenone model does not ideally recapitulate the motor symptoms of Parkinson's disease, that degeneration of the dopaminergic neurons is highly variable, that striatal neurons appear to degenerate more consistently than neurons in the substantia nigra, and that cytoplasmic accumulation of the tau protein is more abundant than alpha-synuclein aggregation in severely lesioned animals. In summary, these data suggest that Rotenone-treated rats model atypical Parkinsonism rather than idiopathic Parkinson's disease.
منابع مشابه
The effect of low dose amphetamine in rotenone-induced toxicity in a mice model of Parkinson’s disease
Objective(s): The effects of low dose amphetamine on oxidative stress and rotenone-induced neurotoxicity and liver injury were examined in vivo in a mice model of Parkinson’s disease. Materials and Methods: Male mice were treated with rotenone (1.5 mg/kg, every other day for two weeks, subcutaneously). Mice received either the vehicle or...
متن کاملProtective Role of Alternanthera Sessilis (Linn.) Silver Nanoparticles and Its Ethanolic Extract against Rotenone Induced Parkinsonism
Biosynthesis of nanoparticles incorporating the herbal extracts can potentially eliminate the toxicity problem. Green synthesis of silver nanoparticles was done by using the ethanolic extract of Alternanthera sessilis (Linn.) and Silver nitrate. The anti-parkinsonism activity of ethanolic extract of Alternanthera sessilis (Linn.) (EEAS) and its silver nanoparticles (ASAgNPs) was evaluated using...
متن کاملControversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD).
A general complex I deficit has been hypothesized to contribute to neurodegeneration in Parkinson's disease (PD) and all toxins used to destroy dopaminergic neurons are complex I inhibitors. With MPTP or 6-OHdopamine, this hypothesis can not be tested since these toxins selectively accumulate in the dopaminergic neurons. However with rotenone, which penetrates all cells, the hypothesis can be t...
متن کاملCommentary: Adenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism
متن کامل
Estrogen agonist genistein differentially influences the cognitive and motor disorders in an ovariectomized animal model of Parkinsonism
Objective(s): Parkinson's disease (PD) is a progressive neurological disorder associated with motor disabilities and cognitive dysfunction as well. Evidence indicates that PD occurs less frequently in women than men, confirming a role for steroid hormones in protection of dopaminergic nigrostriatal neurons. It is reported that soy genistein, an estrogen agonist phytoestrogen, display neuroprote...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of neural transmission. Supplementum
دوره 70 شماره
صفحات -
تاریخ انتشار 2006